Results 221 to 230 of about 53,461 (270)
Some of the next articles are maybe not open access.

Ankylosing Spondylitis

JAMA: The Journal of the American Medical Association, 1977
Ankylosing spondylitis occurs chiefly in young men and affects principally the sacroiliac, apophyseal, and costovertebral joints. Physical findings may be minimal, and special tests may be necessary to find objective evidence of the disease. HLA-B27 histocompatibility antigen is present in 90% to 95% of patients.
openaire   +4 more sources

Ankylosing spondylitis

Nursing Standard, 2006
This article provides an overview of ankylosing spondylitis, a chronic condition characterised by abnormal ossification and ankylosis affecting the spine and sacro-iliac joints. It explores the needs of patients with the condition and identifies pharmacological and non-pharmacological approaches to disease management.
openaire   +2 more sources

Disability in ankylosing spondylitis

Disability and Rehabilitation, 1999
This study was designed to examine the functional loss in ankylosing spondylitis and explore the relationship between disability and various factors such as age, disease duration, disease activity, spinal mobility, chest expansion, peripheral joint involvement, radiological changes, and psychosocial well-being.Forty-two patients were included in this ...
M, Dalyan   +4 more
openaire   +2 more sources

Osteoporosis in Ankylosing Spondylitis

Current Rheumatology Reports, 2010
Osteoporosis (OP) is a frequent complication of ankylosing spondylitis (AS), even in early stages of the disease, and is associated with elevated levels of biochemical markers of bone turnover, proinflammatory cytokines, and acute-phase reactants. This suggests that systemic inflammatory mediators, such as interleukin-6 and tumor necrosis factor-alpha,
Marina, Magrey, Muhammad Asim, Khan
openaire   +2 more sources

Rehabilitation in ankylosing spondylitis

Current Opinion in Rheumatology, 2008
Medical therapy of ankylosing spondylitis has improved dramatically with the advent of anti-tumor necrosis factor therapy, but nonpharmacologic therapies have long been employed to treat the condition. The purpose of this review is to summarize the most recent data to assess the role of exercise and nonpharmacologic therapies in ankylosing spondylitis ...
Francine Ton, Nghiem   +1 more
openaire   +2 more sources

Naproxen in Ankylosing Spondylitis

Scandinavian Journal of Rheumatology, 1973
Naproxen in a daily dose of 500 mg has been prescribed for 23 men with radiographically confirmed ankylosing spondylitis in whom symptoms started before the age of 30. Twenty-three have completed one month and 14 have completed 3 months of treatment. One patient deteriorated but the other 22 found naproxen equal or superior to previous therapy.
H F, Hill, A G, Hill
openaire   +2 more sources

Osteoporosis and ankylosing spondylitis

Joint Bone Spine, 2004
Ankylosing spondylitis is a chronic inflammatory joint disease in which inflammation of the entheses gradually causes local ossification and ankylosis. Diffuse osteoporosis responsible for bone fragility is another feature established by recent data.
openaire   +2 more sources

Management of Ankylosing Spondylitis

Drugs, 1974
Ankylosing spondylitis is a chronic progressive form of arthritis distinguished by involvement of the sacroiliac joints, the spinal apophyseal joints, and the paravertebral soft tissues. Although not a common disorder, ankylosing spondylitis is a clinically important one in that it predominantly affects young males at the prime of their life and at the
openaire   +2 more sources

Ankylosing Spondylitis

Annals of Internal Medicine, 1973
D A, Gordon   +3 more
openaire   +2 more sources

Ankylosing Spondylitis

Clinical Orthopaedics and Related Research, 1964
J, Edeiken, A, DePalma, P J, Hodes
openaire   +2 more sources

Home - About - Disclaimer - Privacy